Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19
AV Kulkarni, P Kumar, HV Tevethia… - Alimentary …, 2020 - Wiley Online Library
Background The incidence of elevated liver chemistries and the presence of pre‐existing
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …
Short-and potential long-term adverse health outcomes of COVID-19: a rapid review
ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of
patients infected worldwide and indirectly affecting even more individuals through disruption …
patients infected worldwide and indirectly affecting even more individuals through disruption …
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
Y Wang, S Liu, H Liu, W Li, F Lin, L Jiang, X Li, P Xu… - Journal of …, 2020 - Elsevier
Background & Aims Liver enzyme abnormalities are common in patients with coronavirus
disease 2019 (COVID-19). Whether or not severe acute respiratory syndrome coronavirus 2 …
disease 2019 (COVID-19). Whether or not severe acute respiratory syndrome coronavirus 2 …
COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection
In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …
SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum
COVID-19 is a systemic infection that exerts significant impact on the metabolism. Yet, there
is little information on how SARS-CoV-2 affects metabolism. Using NMR spectroscopy, we …
is little information on how SARS-CoV-2 affects metabolism. Using NMR spectroscopy, we …
Sympathetic activation: a potential link between comorbidities and COVID‐19
A Porzionato, A Emmi, S Barbon… - The FEBS …, 2020 - Wiley Online Library
In coronavirus disease 2019 (COVID‐19), higher morbidity and mortality are associated with
age, male gender, and comorbidities, such as chronic lung diseases, cardiovascular …
age, male gender, and comorbidities, such as chronic lung diseases, cardiovascular …
[HTML][HTML] Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver
HY Lei, YH Ding, K Nie, YM Dong, JH Xu… - Biomedicine & …, 2021 - Elsevier
COVID-19 is a pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). Early reported symptoms include fever, cough, and respiratory symptoms …
(SARS-CoV-2). Early reported symptoms include fever, cough, and respiratory symptoms …
COVID 19 and liver: An A–Z literature review
The coronavirus pandemic has changed the priorities of the whole medical society. During
the clinical course of COVID-19, it has been observed that hepatic injury occurs in a …
the clinical course of COVID-19, it has been observed that hepatic injury occurs in a …
The plasma metabolome of long COVID patients two years after infection
One of the major challenges currently faced by global health systems is the prolonged
COVID-19 syndrome (also known as “long COVID”) which has emerged as a consequence …
COVID-19 syndrome (also known as “long COVID”) which has emerged as a consequence …
The serum metabolome of moderate and severe COVID-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism
COVID-19 is a global threat that has spread since the end of 2019, causing severe clinical
sequelae and deaths, in the context of a world pandemic. The infection of the highly …
sequelae and deaths, in the context of a world pandemic. The infection of the highly …